Activation of cAMP Dependent Protein Kinase during Surfactant Release from Type II Pneumocytes

References

• Mettler N R, Gray M E, Schuffman S, LeQuire V A. β-Adrenergic induced synthesis and secretion of phosphatidylcholine by isolated pulmonary alveolar type II cells. Lab Invest 1981; 45: 575–586
   PubMed Web of Science ®Google Scholar
• Brown L AS, Longmore W J. Adrenergic and cholinergic regulation of lung surfactant secretion in the isolated perfused rat lung and in the alveolar type II cell in culture. J Biol Chem 1981; 256: 66–72
   PubMed Web of Science ®Google Scholar
• Dobbs L G, Mason R J. Pulmonary alveolar type II cells isolated from rats. J Clin Invest 1979; 63: 378–387
   PubMed Web of Science ®Google Scholar
• Stahlman M T, Gray M E, Lieu S, Chytil F. The role of cyclic AMP in lamellar body synthesis and secretion. Pediatr Res 1974; 8: 470
   Web of Science ®Google Scholar
• Mescher E J, Dobbs L G, Mason R J. Cholera toxin stimulates secretion of saturated phosphatidylcholine and increases cellular cyclic AMP in isolated rat alveolar type II cells. Exp Lung Res 1983; 5: 173–182
   PubMed Web of Science ®Google Scholar
• Pierce M W, Palmer J L, Keutmann H T, Hall T A, Avruch J. The insulin-directed phosphorylation site on ATP-citrate lyase is identical with the site phosphorylated by the cAMP-dependent protein kinase in vitro. J Biol Chem 1982; 257: 10681–10686
   PubMedGoogle Scholar
• Walaas S I, Nairn A C, Greengard P. Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. J Neurosci 1983; 3: 291–301
   PubMed Web of Science ®Google Scholar
• Boivin P, Garbarz M, Dhermy D, Galand C. In vitro phosphorylation of the red blood cell cytoskeleton complex by cyclic AMP-dependent protein kinase from erythrocyte membrane. Biochim Biophys Acta 1981; 647: 1–6
   PubMed Web of Science ®Google Scholar
• Whitsett J A, Matz S, Darovec-Beckerman C. c-AMP-dependent protein kinase and protein phosphorylation in developing rat lung. Pediatr Res 1983; 17: 959–966
   PubMed Web of Science ®Google Scholar
• Seamon K, Daly J W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 1981; 256: 9799–9801
   PubMed Web of Science ®Google Scholar
• Daly J W, Padgett W, Seamon K B. Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: Augmentation of receptor-mediated responses. J Neurochem 1982; 38: 532–544
   PubMed Web of Science ®Google Scholar
• Hersey S J, Owirodu A, Miller M. Forskolin stimulation of acid and pepsinogen secretion by gastric glands. Biochim Biophys Acta 1983; 755: 293–299
   PubMed Web of Science ®Google Scholar
• Adnot S, Desmier M, Ferry N, Hanoune J. Forskolin a powerful inhibitor of human platelet aggregation. Biochem Pharmacol 1982; 31: 4071–4074
   PubMed Web of Science ®Google Scholar
• Greene R M, Ho W C, Lloyd M R. Forskolin induces elevation of cAMP in differentiating embryonic cells. IRCS Med Sci 1982; 10: 999–1000
   Google Scholar
• Stengel D, Guenet L, Desmier M, Insel P, Hanoune J. Forskolin requires more than the catalytic unit to activate adenylate cyclase. Mol Cell Endocrinol 1982; 28: 681–690
   PubMed Web of Science ®Google Scholar
• Morris S A, Bilezikian J P. Evidence that forskolin activates turkey erythrocyte adenylate cyclase through a noncatalytic site. Arch Biochem Biophys 1983; 220: 628–636
   PubMed Web of Science ®Google Scholar
• Sano M, Kitajima S, Mizutani A. Activation of adenylate cyclase by forskolin in rat brain and testis. Arch Biochem Biophys 1983; 220: 333–339
   PubMed Web of Science ®Google Scholar
• Whetton A D, Needham L, Dodd N JF, Heyworth C M, Houslay M D. Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity. Biochem Pharmacol 1983; 32: 1601–1608
   PubMed Web of Science ®Google Scholar
• Darfler J F, Mahan L C, Koachman A M, Insel P A. Stimulation by forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem 1982; 257: 11901–11907
   PubMedGoogle Scholar
• Folch J, Lees M, Sloane-Stanley G H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509
   PubMed Web of Science ®Google Scholar
• Mason R J, Nellenbogen J, Clements J A. Isolation of disaturated phosphatidyl-choline with osmium tetroxide. J Lipid Res 1976; 17: 281–284
   PubMed Web of Science ®Google Scholar
• Rice W R, Osterhoudt K C, Whitsett J A. Effect of cytochalasins on surfactant release from alveolar type II cells. Biochim Biophys Acta 1984; 805: 12–18
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough H J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Steiner A L, Parker C W, Kipnis D M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem 1972; 247: 1106–1113
   PubMed Web of Science ®Google Scholar
• Corbin J D, Keely S L, Park C R. The distribution and dissociation of cyclic adeno-sine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac and other tissues. J Biol Chem 1975; 250: 218–225
   PubMed Web of Science ®Google Scholar
• VanSande J, Cochaux P, Mockel J, Dumont J E. Stimulation by forskolin of the thyroid adenylate cyclase, cyclic AMP accumulation and iodine metabolism. Mol Cell Endocrinol 1983; 29: 109–119
   PubMed Web of Science ®Google Scholar
• Watson E L, Dowd F J. Forskoiin: Effects on mouse parotid gland function. Biochem Biophys Res Commun 1983; 111: 21–27
   PubMed Web of Science ®Google Scholar
• Heisler S, Reisine T, Axelrod J. Desensitization of beta2-adrenergic receptors and adrenocorticotropin release. Biochem Biophys Res Commun 1983; 111: 112–119
   PubMed Web of Science ®Google Scholar
• Litosch I, Hudson T H, Mills I, Li S, Fain J N. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol Pharmacol 1982; 22: 109–115
   Google Scholar
• Malkinson A M, Butley M S. Alterations in cyclic adenosine 3':5'-monophosphate dependent protein kinases during normal and neoplastic lung development. Cancer Res 1981; 41: 1334–1341
   PubMed Web of Science ®Google Scholar
• Doskeland S O, Ogreid D. Binding proteins for cyclic AMP in mammalian tissues. Int J Biochem 1981; 13: 1–19
   PubMedGoogle Scholar
• Cassel D, Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: Inhibition of GTP hydrolysis at the regulatory site. Proc Nati Acad Sci USA 1977; 74: 3307–3311
   PubMed Web of Science ®Google Scholar
• Bender J L, Neer E J. Properties of the adenylate cyclase catalytic unit from caudate nucleus. J Biol Chem 1983; 258: 2432–2439
   PubMed Web of Science ®Google Scholar
• Finkelstein J N, Gallo R L, Notter R H, Shapiro D L. Membrane potential responses of type II cells during surfactant secretion. Pediatr Res 1984; 18: 391A
   PubMedGoogle Scholar
• Mason R J, Dobbs L G, Greenleaf R D, Williams M C. Alveolar type II cells. Fed Proc 1977; 36: 2697–2702
   PubMedGoogle Scholar
• Whitsett J A, Lessard J. Appearance of cAMP dependent actin phosphorylation in rat lung and Type II epithelial cells. Pediatr Res 1984; 18: 147A
   Google Scholar